---
title: "C&Y Pharmaceutical: Ebastine raw material drug approved for market launch"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247606497.md"
description: "C&Y Pharmaceutical announced that its subsidiary Jiangsu Jiayi Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration to market the raw material drug Ebastine. This medication is suitable for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria. The original manufacturer of Ebastine is INDUSTRIAS FARMACEUTICAS ALMIRALL, S.A., and the Ebastine tablets produced by its subsidiary Hangzhou C&Y Pharmaceutical Co., Ltd. have passed the consistency evaluation and have been included in the National Medical Insurance Catalog Category B"
datetime: "2025-07-08T09:23:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247606497.md)
  - [en](https://longbridge.com/en/news/247606497.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247606497.md)
---

# C&Y Pharmaceutical: Ebastine raw material drug approved for market launch

According to the Zhitong Finance APP, C&Y Pharmaceutical (300254.SZ) announced that its subsidiary, Jiangsu Jiayi Pharmaceutical Co., Ltd., has received the approval notice for the listing application of Ebastine from the National Medical Products Administration.

The announcement shows that Ebastine is suitable for symptomatic treatment of allergic rhinitis (seasonal and perennial) with or without allergic conjunctivitis, and chronic idiopathic urticaria

### Related Stocks

- [300254.CN](https://longbridge.com/en/quote/300254.CN.md)

## Related News & Research

- [BREAKINGVIEWS-China's outbound M&A spree has staying power](https://longbridge.com/en/news/286850954.md)
- [US Senator Durbin urges RFK. Jr to resist easing vape rules](https://longbridge.com/en/news/287079463.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [PRECIOUS-Gold edges higher from over 1-1/2-month low but higher yields cap gains](https://longbridge.com/en/news/286745980.md)